Personalised nutrition: How far has nutrigenomics progressed?

European Journal of Clinical Nutrition

Volumn 67, Issue 5, 2013, Pages 430-435

  Hesketh, J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

diet gene interactions; micronutrients; nutrigenomics

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 2; GLUTATHIONE PEROXIDASE 3; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; SELENIUM; SELENOPROTEIN; SODIUM ASCORBIC ACID COTRANSPORTER; SUPEROXIDE DISMUTASE; TRACE ELEMENT;

3' UNTRANSLATED REGION; AMINO ACID SEQUENCE; CODON; FOLATE METABOLISM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEREDITY; HOMOZYGOSITY; HUMAN; LIPID METABOLISM; MATHEMATICAL MODEL; NUTRIGENOMICS; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PERSONALIZED NUTRITION; PROMOTER REGION; PUBLIC HEALTH SERVICE; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

DIET; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HEALTH; HUMANS; INDIVIDUALIZED MEDICINE; LIPID METABOLISM; MICRONUTRIENTS; NUTRIGENOMICS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NUTRITIONAL SCIENCES; NUTRITIONAL STATUS;

EID: 84877150333     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.145     Document Type: Review

References (61)

1. Debusk RM, Fogarty CP, Ordovas JM, Kornman KS. Nutritional genomics in practice: Where do we begin̈J Amer Diet Assn 2005; 105: 589-598
2. Peters BA, Kermani BG, Sparks AB, Alferov O, Hong P, Alexeev A et al. Nature 2012; 487: 190-195
3. Jacobs B, De Angelis-Schierbaum G, Egert S, Assmann G, Kratz M. Individual serum triglyceride responses to high-fat and low-fat diets differ in men with modest and severe hypertriglyceridemia. J Nutr 2004; 134: 1400-1405
4. Loktionov A. Common gene polymorphisms and nutrition: Emerging links with pathogenesis of multifactorial chronic diseases. J Nutr Biochem 2003; 14: 426-451
5. Corella D, Ordovas JM. Single nucleotide polymorphisms that influence lipid metabolism: Interaction with dietary factors. Annu Rev Nutr 2005; 25: 341-390
6. Genest Jr. JJ, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992; 85: 2025-2033
7. Joost HG, Gibney MJ, Cashman KD, Görman U, Hesketh JE, Mueller M et al. Personalised nutrition: Status and perspectives. Br J Nutr 2007; 98: 26-31
8. Haggarty P. B-vitamins, genotype and disease causality. Proc Nutr Soc 2007; 66: 539-47
9. Ulrich CM, Potter JD. Folate supplementation: Too much of a good thing̈Cancer Epidemiol Biomarkers Prev 2006; 15: 189-193
10. Fairweather-Tait SJ, Bao Y, Broadley MR, Collings R, Ford D, Hesketh JE et al. Selenium in human health and disease. Antiox Red Signal 2011; 14: 1337-1383
11. Hesketh JE. Nutrigenomics and selenium: Gene expression patterns, physiological targets, and genetics. Annu Rev Nutr 2008; 28: 157-177
12. Hesketh J, Meplan C. Transcriptomics and functional genetic polymorphisms as biomarkers of micronutrient function: Focus on selenium as an exemplar. Proc Nutr Soc 2011; 3: 1-9
13. Forsberg L, de Faire U, Marklund SL, Andersson PM, Stegmayr B, Morgenstern R. Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1. Blood Cells Mol Dis 2000; 26: 423-426
14. Jablonska E, Gromadzinska J, Reszka E, Wasowicz W, Sobala W, Szeszenia-Dabrowska N et al. Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans. Eur J Nutr 2009; 48: 383-386
15. Villette S, Kyle JA, Brown KM, Pickard K, Milne JS, Nicol F et al. A novel single nucleotide polymorphism in the 30 untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol Dis 2002; 29: 174-178
16. Meplan C, Crosley LK, Nicol F, Horgan GW, Mathers JC, Arthur Jr. et al. Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: Interaction with sex. Am J Clin Nutr 2008; 87: 1019-1027
17. Gautrey H, Nicol F, Sneddon AA, Hall J, Hesketh J. A T/C polymorphism in the GPX4 30UTR affects the selenoprotein expression pattern and cell viability in transfected Caco-2 cells. Biochim Biophys Acta 2011; 1810: 284-291
18. Burk RF, Hill KE. Selenoprotein P -Expression, functions, and roles in mammals. Biochim Biophys Acta 2009; 1790: 1441-1447
19. Al-Taie OH, Uceyler N, Eubner U, Jakob F, Mork H, Scheurlen M et al. Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis. Nutr Cancer 2004; 48: 6-14
20. Meplan C, Crosley LK, Nicol F, Beckett GJ, Howie AF, Hill KE et al. Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J 2007; 21: 3063-3074
21. Meplan C, Nicol F, Burtle BT, Crosley LK, Arthur JR, Mathers JC et al. Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, se intake, and cancer status. Antioxid Redox Signal 2009; 11: 2631-2640
22. Curran JE, Jowett JB, Elliott KS, Gao Y, Gluschenko K, Wang J et al. Genetic variation in selenoprotein S influences inflammatory response. Nature Genet 2005; 37: 1234-1241
23. Lietz G, Lange J, Rimbach G. Molecular and dietary regulation of beta,beta-carotene 15,150-monooxygenase 1 (BCMO1). Arch Biochem Biophys 2010; 502: 8-16
24. Borel P, Grolier P, Mekki N, Boirie Y, Rochette Y, LeRoy B et al. Low and high responders to pharmacological doses of beta-carotene: Proportion in the population, mechanisms involved and consequences on beta-carotene metabolism. J Lipid Res 1998; 39: 2250-2260
25. Hickenbottom SJ, Follett JR, Lin Y, Dueker SR, Burri BJ, Neidlinger TR et al. Variability in conversion of beta-carotene to vitamin A in men as measured by using a double-Tracer study design. Am J Clin Nutr 2002; 75: 900-907
26. Leung W, Hessel S, Me'plan C, Flint J, Oberhauser V, Tourniaire F et al. Two common single nucleotide polymorphisms in the gene encoding b-carotene 15,150-monoxygenase alter b-carotene metabolism in female volunteers. FASEB J 2009; 23: 1041-1053
27. Ferrucci L, Perry JR, Matteini A, Perola M, Tanaka T, Silander K et al. Common variation in the beta-carotene 15,150-monooxygenase 1 gene affects circulating levels of carotenoids: A genome-wide association study. Am J Hum Genet 2009; 84: 123-133
28. Lietz G, Oxley A, Leung W, Hesketh J. Single nucleotide polymorphisms upstream from the b-carotene 15,150-monoxygenase gene influence provitamin A conversion efficiency in female volunteers. J Nutr 2012; 142: 161S-165S.
29. Borel P, Moussa M, Reboul E, Lyan B, Defoort C, Vincent-Baudry S et al. Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. J Nutr 2007; 137: 2653-2659
30. Borel P, Moussa M, Reboul E, Lyan B, Defoort C, Vincent-Baudry S et al. Human fasting plasma concentrations of vitamin E and carotenoids, and their association with genetic variants in apo C-III, cholesteryl ester transfer protein, hepatic lipase, intestinal fatty acid binding protein and microsomal triacylglycerol transfer protein. Br J Nutr 2009; 101: 680-687
31. Zhong H, Yang X, Kaplan LM, Molony C, Schadt EE. Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am J Hum Genet 2010; 86: 581-591
32. McNulty H, Scott JM. Intake and status of folate and related B-vitamins: Considerations and challenges in achieving optimal status. Br J Nutr 2008; 99: S48-S54
33. Castillo-Lancellotti C, Tur JA, Uauy R. Impact of folic acid fortification of flour on neural tube defects: A systematic review. Public Health Nutr 2012; 31: 1-11
34. Greene ND, Stanier P, Copp AJ. Genetics of human neural tube defects. Hum Mol Genet 2009; 18: R113-R129
35. Sutherland A, Kim DH, Relton C, Ahn YO, Hesketh J. Polymorphisms in the selenoprotein S and 15-kDa selenoprotein genes are associated with altered susceptibility to colorectal cancer. Genes Nutr 2010; 5: 215-223
36. Meplan C, Hughes DJ, Pardini B, Naccarati A, Soucek P, Vodickova L et al. Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis 2010; 31: 1074-1079
37. Shibata T, Arisawa T, Tahara T, Ohkubo M, Yoshioka D, Maruyama N et al. Selenoprotein S (SEPS1) gene -105G4A promoter polymorphism influences the susceptibility to gastric cancer in the Japanese population. BMC Gastroenterol 2009; 9: 2
38. Penney KL, Schumacher FR, Li H, Kraft P, Morris JS, Kurth T et al. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res 2010; 3: 604-610
39. Haug U, Poole EM, Xiao L, Curtin K, Duggan D, Hsu L et al. Glutathione peroxidase tagSNPs: Associations with rectal cancer but not with colon cancer. Genes Chromosomes Cancer 2012; 51: 598-605
40. Peters U, Chatterjee N, Hayes RB, Schoen RE, Wang Y, Chanock SJ et al. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2008; 17: 1144-1154
41. Jablonska E, Gromadzinska J, Sobala W, Reszka E, Wasowicz W. Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. Eur J Nutr 2008; 47: 47-54
42. Steinbrecher A, Meplan C, Hesketh J, Schomburg L, Endermann T, Jansen E et al. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol Biomarkers Prev 2010; 19: 2958-2968
43. Da Costa LA, Badawi A, El-Sohemy A. Nutrigenetics and modulation of oxidative stress. Ann Nutr Metab 2012; 60: 27-36
44. Timpson NJ, Forouhi NG, Brion MJ, Harbord RM, Cook DG, Johnson P et al. Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-Ascorbic acid (vitamin C): Evidence from 5 independent studies with 415 000 participants. Am J Clin Nutr 2010; 92: 375-382
45. Cooper ML, Adami HO, Grönberg H, Wiklund F, Green FR, Rayman MP. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res 2008; 68: 10171-10177
46. Mao C, Qiu LX, Zhan P, Xue K, Ding H, Du FB et al. MnSOD Val16Ala polymorphism and prostate cancer susceptibility: A meta-Analysis involving 8962 subjects. J Cancer Res Clin Oncol 2010; 136: 975-979
47. Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Vena JE, Marshall Jr. et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 1999; 59: 602-606
48. Knoblauch H, Bauerfeind A, Toliat MR, Becker C, Luganskaja T, Günther UP et al. Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol. Hum Mol Genet 2004; 13: 993-1004
49. Imamura M, Maeda S. Genetics of type 2 diabetes: The GWAS era and future perspectives. Endocr J 2011; 58: 723-739
50. Lees CW, Barrett JC, Parkes M, Satsangi J. New IBD genetics: Common pathways with other diseases. Gut 2012; 60: 1739-1753
51. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T et al. Metaanalysis of genome-wide association data and largescale replication identifies additional susceptibility loci for type 2 diabetes. Nature Genet 2008; 40: 638-645
52. Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H. Heritability of type II (non-insulindependent) diabetes mellitus and abnormal glucose tolerance-A population based twin study. Diabetologia 1999; 42: 139-145
53. Aschard H, Lutz S, Maus B, Duell EJ, Fingerlin TE, Chatterjee N et al. Challenges and opportunities in genome-wide environmental interaction (GWEI) studies. Hum Genet 2012; 131: 1591-613
54. Thomas D. Gene-environment-wide association studies: Emerging approaches. Nature Rev Genet 2010; 11: 259-272
55. Zhang Y. A novel bayesian graphical model for genome-wide multi-SNP association mapping. Genet Epidemiol 2012; 36: 36-47
56. Lill CM, Bertram L. Developing the "next generation" of genetic association databases for complex diseases. Hum Mutat 2012; 33: 1366-1372
57. Me'plan C, Hesketh JE. Selenium and cancer: A story that should not be forgotten -insights from genomics. Cancer Treat Res 2012 (in press
58. Ulrich CM, Neuhouser M, Liu AY, Boynton A, Gregory JF, Shane B et al. Mathematical modeling of folate metabolism: Predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis. Cancer Epidemiol Biomarkers Prev 2008; 17: 1822-1831
59. Lluis-Ganella C, Subirana I, Lucas G, Tomá s M, Mun̈oz D, Sentí M et al. Assessment of the value of a genetic risk score in improving the estimation of coronary risk. Atherosclerosis 2012; 222: 456-463
60. Favé G, Beckmann M, Lloyd AJ, Zhou S, Harold G, Lin W et al. Development and validation of a standardized protocol to monitor human dietary exposure by metabolite fingerprinting of urine samples. Metabolomics 2011; 7: 469-484
61. Scalbert A, Brennan L, Fiehn O, Hankemeier T, Kristal BS, van Ommen B et al. Mass-spectrometry-based metabolomics: Limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics 2009; 5: 435-458